AIM ImmunoTech Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
AIM ImmunoTech Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • AIM ImmunoTech Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.83M, a 2729% increase year-over-year.
  • AIM ImmunoTech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $485K, a 506% increase from 2022.
  • AIM ImmunoTech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $80K, a 99% decline from 2021.
  • AIM ImmunoTech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $8.19M, a 85.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $485K +$405K +506% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $80K -$8.11M -99% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $8.19M -$48.4M -85.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $56.6M +$40.2M +245% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $16.4M +$6.95M +73.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $9.44M +$5.22M +124% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $4.22M -$542K -11.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $4.76M -$4.9M -50.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 $9.66M -$3.13M -24.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-30
2014 $12.8M +$19.6M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-31
2013 -$6.85M -$35.2M -124% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-19
2012 $28.3M +$26.7M +1643% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-19
2011 $1.62M +$1.37M +550% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $250K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.